Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.
| Market Capitalization | $595.4103 million |
| P/E Ratio | 16.54 |
| P/E Growth Ratio | |
| Book Value | 0.86 |
| Dividend Per Share | 0.14 |
| Earnings Per Share | 0.18 |
| EBITDA | 78,504 |
| Profit Margin | 0.0515 |
| Operating Margin TTM | 0.0918 |
| Return on Assets TTM | 0.0663 |
| Return on Equity TTM | 0.1779 |
| Revenue TTM | 697,072 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2016-12-31 | 339,768 | 57,679 | 282,089 | |
| 2017-12-31 | 379,245 | 65,960 | 313,285 | |
| 2018-12-31 | 448,455 | 79,413 | 369,042 | |
| 2019-12-31 | 490,570 | 87,040 | 403,530 | |
| 2020-12-31 | 641,311 | 119,585 | 521,726 | 416,536 |
| 2021-12-31 | 989,298 | 207,592 | 781,706 | 514,029 |
| 2022-12-31 | 692,103 | 126,083 | 566,020 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2016-12-31 | 7,036 | 120,893 | 106,771 | 0 | 48,244 | 109,515 |
| 2017-12-31 | 6,867 | 119,058 | 113,600 | 0 | 52,213 | 109,515 |
| 2018-12-31 | 4,131 | 153,610 | 126,190 | 0 | 55,999 | 146,505 |
| 2019-12-31 | 34,849 | 366,053 | 297,065 | 0 | 60,070 | 146,505 |
| 2020-12-31 | 35,233 | 474,701 | 392,787 | 70,206 | 99,511 | 797,975 |
| 2021-12-31 | 26,372 | 628,042 | 395,485 | 94,767 | 0 | 793,031 |
| 2022-12-31 | 19,955 | 578,913 | 406,242 | 65,696 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2016-12-31 | -24,031 | 4,603 | 6,051 | |||
| 2017-12-31 | -9,012 | 4,693 | -169 | 42,000 | ||
| 2018-12-31 | -10,524 | 1,112 | -2,736 | 42,000 | ||
| 2019-12-31 | 41,255 | 101,736 | 30,718 | 34,849 | 42,000 | |
| 2020-12-31 | 60,373 | 153,864 | 384 | 34,849 | 35,233 | 42,000 |
| 2021-12-31 | 178,244 | 284,087 | -8,861 | 35,233 | 26,372 | 24,279 |
| 2022-12-31 | 35,901 | -6,377 | 26,372 | 19,955 | 96,880 |